Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Istituto Oncologico Romagnolo (IOR) | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
This an interventional, non-pharmacologic study. Prehabilitation is a multidisciplinary preoperative intervention aimed at preventing or reducing functional decline related to surgery and improving perioperative outcomes. The current study is aimed at standardizing a prehabilitation pathway, evaluating its feasibility within the AUSL Romagna in collaboration with the PRIME Centre and the multiple professions that populate the two institutes in the spirit of confirming the beneficial effect of an integrated prehabilitation programme on surgical outcomes.
Patients will follow an intensive prehabilitation course before surgery:
The prehabilitation course is structured around the following aspects:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Colorectal cancer patients | Experimental | Patients with colon or rectal cancer awaiting surgery |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Prehabilitation course | Other | During prehabilitation course, patients will follow a nutritional programme, a cardiovascular and motor programme and a psychological programme. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of eligible participants completed the personalized proposed prehabilitation program | The primary endpoint of the study will be the feasibility of delivering a prehabilitation program, based on adherence. This study will be deemed as feasible if ≥80% of eligible participants completed the personalized proposed prehabilitation program. | 4 months |
| Measure | Description | Time Frame |
|---|---|---|
| Adherence to prescription | Percentage of patients with compliance greater than 80% to prehabilitation prescription | 4 months |
| 30-days mortality | Proportion of patients who died for all causes within 30 days after the surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Isacco Montroni, MD | Contact | 0544 285111 | isacco.montroni@auslromagna.it | |
| Centro di Coordinamento | Contact | 0544 287173 | cc.ubsc@irst.emr.it |
| Name | Affiliation | Role |
|---|---|---|
| Isacco Montroni, MD | AUSL della Romagna | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| AUSL della Romagna | Recruiting | Ravenna | RA | 48100 | Italy |
Not provided
| ID | Term |
|---|---|
| D003110 | Colonic Neoplasms |
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 30 days after the surgery |
| Overall morbidity rate and major morbidity rate | Calculated according Clavien-Dindo classification | 4 months |
| Preservation/improvement of pre-operative quality of life before vs. 1-month after surgery | Questionnaire EQ-5D-3L. Test results are presented in the form of an index and a VAS scale. The index is based on patients' quality of life in 5 domains across 3 levels. Distribution of EQ-5D-3L dimension responses at different times were calculated. The index, which is a value attached to an EQ-5D-3L profile according to a set of weights that reflect, on average, people's preferences about how good or bad the state is, ranges from 0 (poorest quality of life) to 1 (perfect health). The value set generated from the European population (EQ) was used as the reference cohort for index calculation. The VAS score is generated by asking the patient how he/she ranked his/her QoL, as compared to his/her peers, on a scale from 0 to 100, where higher values were associated to a better quality of life. EQ-5D-3L index and VAS were expressed as mean (Standard Deviation-SD) and median (minimum-maximum), while frequency will be calculated for categorical variables (five domains of EQ-5D-3L). | 30 days after the surgery |
| Preservation/improvement of pre-operative quality of life before vs. 1-month after surgery. | Questionnaire EORTC QLQ-ELD14, a questionnaire that comprise five scales (mobility, worries about others, future worries, maintaining purpose and burden of illness) and two single items (joint stiffness and family support). Four levels were available for the response (1=not at all, 2=a little, 3=quite a bit, 4=very much). Distribution of EORTC QLQ-ELD14 items at different times were calculated. All scale and item scores are transformed to a 0-100 scale, higher scores representing a worse outcome except for maintaining purpose and family support. EORTC QLQ-ELD14 scores were expressed as mean (Standard Deviation-SD) and median (minimum-maximum), while frequency will be calculated for categorical variables (for the five scales and two single items). | 30 days after the surgery |
| Postoperative functional recovery at one month after surgery | Percentage of patients experiences functional recovery as described in protocol. | 30 days after the surgery |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |